Fundraising FoxCatalys Pacific — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Mineralys Therapeuticsmineralystx.comin𝕏NASDAQ: MLYSJun 2022
Mineralys Therapeutics is a clinical-stage pharmaceutical company developing lorundrostat, a treatment targeting dysregulated aldosterone.
BiotechHealthtechRadnor, US
Eric Warren(Chief Commercial Officer)inAlex Gold(Chief Medical Officer)inAdam Levy(Executive Officer)Alexander Asam(Director)
BoardOlivier Litzka(Director)in
Board seatTakeshi TakahashiBrian Taylor Slingsby· per SEC Form D
Co-investorsAndera PartnersHBM Healthcare InvestmentsHBM PartnersSamsara BioCapitalSR One Capital ManagementYsios Capital+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.